Bonviva
150 mg film-coated tablets Ibandronic acid
Bonviva belongs to a group of medicines called bisphosphonates. It contains the active substance ibandronic acid.
Bonviva can reverse bone loss because it prevents further bone loss and increases bone mass in most women who take it, even if they cannot see or feel the difference. Bonviva may help reduce the likelihood of bone fractures. This reduction has been shown in spinal fractures but not in hip fractures.
You have been prescribed Bonviva to treat your postmenopausal osteoporosis because you are at high risk of fractures. Osteoporosis is a condition where bones become thinner and weaker, which is common in women after the menopause. During the menopause, the ovaries stop producing the female hormone oestrogen, which helps to keep bones healthy.
The earlier a woman reaches the menopause, the higher her risk of fractures due to osteoporosis. Other factors that increase the risk of fractures are:
Healthy lifestyle habitsalso help the beneficial effects of treatment. These include:
Do not take Bonviva:
Warnings and precautions
A very rare side effect called osteonecrosis of the jaw (ONJ) (bone damage in the jaw) has been reported in patients treated with Bonviva for osteoporosis. ONJ can also occur after stopping treatment.
It is important to try to prevent the development of ONJ as it is a painful condition that can be difficult to treat. To reduce the risk of developing osteonecrosis of the jaw, certain precautions should be taken.
Atypical fractures of long bones, such as the forearm (cubitus) and shinbone (tibia), have also been reported in patients receiving long-term treatment with ibandronate. These fractures occur after minimal or no trauma and some patients experience pain in the area of the fracture before a complete fracture occurs.
Before treatment, inform your doctor/nurse (healthcare professional) if:
Your doctor may ask you to have a dental examination before starting treatment with Bonviva.
While you are being treated, you should maintain good oral hygiene (including regular tooth brushing) and have regular dental check-ups. If you wear dentures, you should ensure they fit properly. If you are undergoing dental treatment or are about to undergo dental surgery (e.g. tooth extraction), inform your doctor about your dental treatment and inform your dentist that you are being treated with Bonviva.
Contact your doctor and dentist immediately if you experience any problems with your mouth or teeth, such as tooth loss, pain or swelling, or difficulty healing of ulcers or discharge, as these may be signs of osteonecrosis of the jaw.
Some people need special care when taking Bonviva. Consult your doctor before taking Bonviva:
Irritation, inflammation or ulceration of the gullet (oesophagus) may occur, often with symptoms of severe chest pain, severe pain after swallowing food or drink, severe nausea or vomiting, especially if patients do not drink a full glass of water and/or if they lie down less than 60 minutes after taking Bonviva. If you develop these symptoms, stop taking Bonviva and inform your doctor immediately (see section 3).
Do not give Bonviva to children or adolescents under 18 years of age.
Other medicines and Bonviva
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Especially:
After taking the monthly Bonviva tablet, wait 1 hour before taking any other medicine, including antacids, calcium or vitamin supplements.
Bonviva with food and drinks:
Do not take Bonviva with food. Bonviva loses its effect if taken with food.
You can drink water but not other liquids.
After taking Bonviva, wait 1 hour before taking your first food and other drinks (see section 3 How to take Bonviva).
Bonviva is only for use in postmenopausal women and should not be taken by women of childbearing potential. Do not take Bonviva if you are pregnant or breast-feeding.
Consult your doctor or pharmacist before using this medicine.
You can drive and use machines as Bonviva is not expected to affect your ability to drive or use machines.
Bonviva contains lactose.
If your doctor has told you that you have an intolerance to some sugars, consult your doctor before taking this medicine.
Follow exactly the instructions for administration of this medicine as given by your doctor. If you are not sure, consult your doctor or pharmacist.
It is important that you follow these instructions carefully. They are designed to help Bonviva reach the stomach and cause less irritation.
Do not take the tablet with water with a high concentration of calcium, fruit juice or other drinks. If you are unsure about the potentially high calcium levels in your tap water (hard water), it is recommended to use bottled water with low mineral content.
Continuation of treatment with Bonviva
It is important that you take Bonviva every month, for as long as your doctor prescribes it. After 5 years of taking Bonviva, consult your doctor to see if you should continue taking Bonviva.
If you take more Bonviva than you should
If you have taken too many tablets by mistake, drink a full glass of milk and contact your doctor immediately.
Do not induce vomiting or lie downbecause this could irritate the oesophagus.
If you forget to take Bonviva
If you forget to take the tablet on the morning of the day you have chosen, do not take it later
Instead, consult your calendar to see when your next dose is due
Take one tablet the next morning after the day you remember you forgot the dose, then take one tablet per month according to the days marked on your calendar
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor or nurse immediately if you notice any of the following serious side effects, as you may need urgent medical treatment:
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Other possible side effects
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children. No special storage conditions are required.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date is the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
What Bonviva contains:
tablet core: lactose monohydrate, povidone, microcrystalline cellulose, crospovidone, purified stearic acid, anhydrous colloidal silica
tablet coating: hypromellose, titanium dioxide (E 171), talc, macrogol 6000
Appearance and packaging
Bonviva tablets are white or almost white, oblong and have the inscription “BNVA” on one side and “150” on the other side. They can be supplied in packs of 1 or 3 tablets.
Not all pack sizes may be marketed.
Atnahs Pharma Netherlands B.V.
Copenhagen Towers,
Ørestads Boulevard 108, 5.tv
DK-2300 København S
Denmark
IL CSM Clinical Supplies Management GmbH
Marie-Curie-Strasse 8
Lörrach
Baden-Württemberg
79539, Germany
Atnahs Pharma Denmark ApS,
Copenhagen Towers,
Ørestads Boulevard 108, 5.tv
DK-2300 København S
Denmark
Detailed information on this medicine is available on the European Medicines Agency web site http://www.ema.europa.eu
The dose of Bonviva is one tablet per month. Choose a day of the month that you can easily remember: either the same date (e.g. the first day of each month)
or always the same day (e.g. the first Sunday of each month).
It is important to take Bonviva every month.